Molecular Tumor Board treatment predictions on rare EGFR exon 20 mutations

被引:0
|
作者
van der Wekken, Anthonie J.
Groves, Matthew R.
ter Elst, Arja
't Hart, Nils A.
Hijmering-Kappelle, Lucie B.
Hiltermann, Thijo J.
van den Berg, Anke
Timens, Wim
Schuuring, Ed
Groen, Harry J.
机构
关键词
D O I
10.1158/1538-7445.AM2017-2718
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2718
引用
收藏
页数:2
相关论文
共 50 条
  • [31] The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation
    Man, Xiuyue
    Sun, Xueru
    Chen, Chen
    Xiang, Yan
    Zhang, Jing
    Yang, Lei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [32] Treatment Patterns and Clinical Outcomes among Advanced NSCLC Patients with EGFR exon 20 Insertion Mutations in China
    Wang, Y.
    Lin, H. M.
    Ning, N.
    Du, F.
    Gao, X.
    Dong, Q.
    Yang, G.
    Xu, H.
    He, Y.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S609 - S609
  • [33] Sensitivity of EGFR exon 20 insertion mutations to EGFR inhibitors is determined by their location within the tyrosine kinase domain of EGFR
    Yasuda, Hiroyuki
    Sng, Natasha J.
    Yeo, Wee-Lee
    Figueiredo-Pontes, Lorena L.
    Kobayashi, Susumu
    Costa, Daniel B.
    CANCER RESEARCH, 2012, 72
  • [34] SENSITIVITY OF EGFR EXON 20 INSERTION MUTATIONS TO EGFR INHIBITORS IS DETERMINED BY THEIR LOCATION WITHIN THE TYROSINE KINASE DOMAIN OF EGFR
    Yasuda, Hiroyuki
    Figueiredo-Pontes, Lorena L. D.
    Tenen, Daniel G.
    Kobayashi, Susumu
    Costa, Daniel B.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : S107 - S107
  • [35] Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma
    Yunjian Pan
    Yang Zhang
    Yuan Li
    Haichuan Hu
    Lei Wang
    Hang Li
    Rui Wang
    Ting Ye
    Xiaoyang Luo
    Yiliang Zhang
    Bin Li
    Deng Cai
    Lei Shen
    Yihua Sun
    Haiquan Chen
    Annals of Surgical Oncology, 2014, 21 : 490 - 496
  • [36] Prevalence, Clinicopathologic Characteristics, and Molecular Associations of EGFR Exon 20 Insertion Mutations in East Asian Patients with Lung Adenocarcinoma
    Pan, Yunjian
    Zhang, Yang
    Li, Yuan
    Hu, Haichuan
    Wang, Lei
    Li, Hang
    Wang, Rui
    Ye, Ting
    Luo, Xiaoyang
    Zhang, Yiliang
    Li, Bin
    Cai, Deng
    Shen, Lei
    Sun, Yihua
    Chen, Haiquan
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S490 - S496
  • [37] The prediction of treatment outcome in NSCLC patients harboring an EGFR exon 20 mutation using molecular modeling
    Zwierenga, F.
    Zhang, L.
    Melcr, J.
    Schuuring, E.
    van Veggel, B. A. M. H.
    de Langen, A. J.
    Groen, H. J. M.
    Groves, M. R.
    van der Wekken, A. J.
    LUNG CANCER, 2024, 197
  • [38] Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC
    Goldberg, Michael E.
    Montesion, Meagan
    Young, Lauren
    Suh, James
    Greenbowe, Joel
    Kennedy, Mark
    Giaccone, Giuseppe
    Akerley, Wallace L.
    Dowlati, Afshin
    Creelan, Benjamin C.
    Hicks, James K.
    Hesketh, Paul J.
    Kelly, Karen L.
    Riess, Jonathan W.
    Miller, Vincent A.
    Stephens, Philip J.
    Frampton, Garrett M.
    Ali, Siraj
    Gregg, Jeffrey P.
    Albacker, Lee A.
    PLOS ONE, 2018, 13 (11):
  • [39] Structural Mechanism and Inhibitors Targeting EGFR Exon 20 Insertion (Ex20ins) Mutations
    Chen, Hao
    Hu, Shiliang
    Patterson, Adam V.
    Smaill, Jeff B.
    Ding, Ke
    Lu, Xiaoyun
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, : 11656 - 11671
  • [40] Sensitivity to EGFR inhibitors based on location of EGFR exon 20 insertion mutations within the tyrosine kinase domain of EGFR.
    Costa, Daniel Botelho
    Yasuda, Hiroyuki
    Sng, Natasha J.
    Yeo, Wee-Lee
    de Figueiredo-Pontes, Lorena Lobo
    Tenen, Daniel G.
    Kobayashi, Susumu
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)